Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary care

  • Peter Bramlage, Eleonore Schönrock, Peter Odoj
  • BMC Cardiovascular Disorders, November 2008, Springer Science + Business Media
  • DOI: 10.1186/1471-2261-8-30

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1186/1471-2261-8-30

The following have contributed to this page: Peter Bramlage